BlackRock Fund Advisors’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $146M | Buy |
3,057,681
+179,570
| +6% | +$8.59M | 0.03% | 892 |
|
|
2016
Q3 | $105M | Buy |
2,878,111
+77,715
| +3% | +$2.85M | 0.02% | 1017 |
|
|
2016
Q2 | $65.2M | Buy |
2,800,396
+45,922
| +2% | +$1.07M | 0.01% | 1317 |
|
|
2016
Q1 | $112M | Buy |
2,754,474
+149,937
| +6% | +$6.07M | 0.03% | 872 |
|
|
2015
Q4 | $161M | Sell |
2,604,537
-188,458
| -7% | -$11.7M | 0.04% | 611 |
|
|
2015
Q3 | $113M | Buy |
2,792,995
+175,032
| +7% | +$7.07M | 0.03% | 814 |
|
|
2015
Q2 | $151M | Sell |
2,617,963
-1,976,136
| -43% | -$114M | 0.04% | 664 |
|
|
2015
Q1 | $293M | Buy |
4,594,099
+122,641
| +3% | +$7.81M | 0.07% | 306 |
|
|
2014
Q4 | $276M | Buy |
4,471,458
+351,000
| +9% | +$21.7M | 0.07% | 306 |
|
|
2014
Q3 | $160M | Sell |
4,120,458
-13,240
| -0.3% | -$514K | 0.05% | 506 |
|
|
2014
Q2 | $142M | Sell |
4,133,698
-249,389
| -6% | -$8.59M | 0.04% | 612 |
|
|
2014
Q1 | $189M | Buy |
4,383,087
+175,355
| +4% | +$7.58M | 0.06% | 404 |
|
|
2013
Q4 | $168M | Sell |
4,207,732
-66,257
| -2% | -$2.64M | 0.05% | 465 |
|
|
2013
Q3 | $160M | Buy |
4,273,989
+598,421
| +16% | +$22.5M | 0.05% | 425 |
|
|
2013
Q2 | $98.8M | Buy |
+3,675,568
| New | +$98.8M | 0.04% | 667 |
|